The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 1.

Table. 1.

Clinical characteristics of the recipients

KT LT P value
No. of recipients 38 30
Recipient age, median (IQR) 42.5 (36.0∼55.0) 52.0 (49.0∼59.1) <0.01
Recipient, male (%) 19 (50.0) 23 (76.7) 0.04
Underlying disease DM nephropathy 10 (26.3) HCV with LC 21 (70.0)
IgA 7 (18.4) LC 7 (23.3)
GN 3 (7.9) PBC 2 (6.7)
ADPCK 3 (7.9)
Other 7 (18.4)
Unknown 8 (21.1)
Initial log2 anti-donor IA IgM titer, median (IQR) 6.0 (5.0∼7.0) 6.0 (5.0∼8.0) 0.20
Initial log2 anti-donor IA IgG titer, median (IQR) 8.0 (6.0∼10.0) 9.0 (8.0∼10.0) 0.01
Initial calculated globulin (mg/dL), median (IQR) 2.6 (2.3∼2.9) 2.8 (2.5∼3.2) 0.04
Plasmapheresis 38 (100.0) 30 (100.0)
Induction therapy
ATG+RTX 36 (94.7) 0 (0.0)
RTX+Basiliximab 0 (0.0) 14 (46.7)
RTX 0 (0.0) 16 (53.3)
ATG 2 (5.3) 0 (0.0)
Maintenance
FK+MMF+PD 38 (100.0) 30 (100.0)
Donor ABO type
A (%) 19 (50.0) 15 (50.0) 0.90
B (%) 16 (42.1) 12 (40.0)
AB (%) 3 (7.9) 3 (10.0)

Abbreviations: KT, kidney transplant; LT, liver transplant; IQR, interquartile range; ATG, anti-thymocyte globulin; RTX, rituximab; FK, FK506; MMF, mycophenolate mofetil; PD, prednisolone; DM, diabetes mellitus; IgA, IgA nephropathy; GN, glomerulonephritis; ADPCK, autosomal dominant polycystic kidney; HCV, hepatitis C virus; LC, liver cirrhosis; PBC, primary biliary cirrhosis.

Korean J Blood Transfus 2021;32:112-22 https://doi.org/10.17945/kjbt.2021.32.2.112
© 2021 Korean J Blood Transfus